ADVAGEN

What this means for you

Not registered yet, but its 05 Jan 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

98344686

Mark type

Stylized text

Filed

05 Jan 2024

Published for opposition

19 Nov 2024

Attorney of record

WILLIAM SCOTT GOLDMAN

Goods and services

• Class 005 — Pharmaceuticals: Dietary Supplements; Nutritional Supplements; Cardiovascular pharmaceutical preparations; Pharmaceutical agents affecting metabolism; Digestives for pharmaceutical purposes; Dextrins for pharmaceutical use; Starch for pharmaceutical purposes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for treating allergic rhinitis; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for the prevention of osteoporosis; Pharmaceutical products for the treatment of cancer; Pharmaceutical preparations for the central nervous system; Plant extracts, other than essential oils, for pharmaceutical purposes; Plant extracts, other than essential oils, for medical, veterinary and pharmaceutical purposes; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical products for the treatment of infectious diseases; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical preparations for the treatment of musculoskeletal disorders; Therapeutic pharmaceutical for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Vitamin and mineral supplements for use as ingredients in the food and pharmaceutical industry; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Chemical preparations for pharmaceutical or medical purposes, namely, for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; All aforementioned goods not for use in parenteral nutrition

Owner

• ADVAGEN PTE. LTD., Singapore, SG
• ADVAGEN PTE. LTD., Singapore, SG

Prosecution history

• 20 Mar 2025 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
• 19 Mar 2025 — OPPOSITION INSTITUTED NO. 999999
• 19 Dec 2024 — EXTENSION OF TIME TO OPPOSE RECEIVED
• 19 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 19 Nov 2024 — PUBLISHED FOR OPPOSITION
• 13 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 09 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 03 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 02 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 02 Oct 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 28 Sept 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 28 Sept 2024 — NON-FINAL ACTION E-MAILED
• 28 Sept 2024 — NON-FINAL ACTION WRITTEN
• 06 Aug 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 05 Aug 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE